Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicolas Duployez

Showing results (121-130 of 142) with videos related to

Pageof 15
Sort By:
Leukemia|March 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemiaLoïc Vasseur, Matthieu Duchmann, Nicolas Duployez, et al.
British Journal of Haematology|April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutationsLionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood Cancer Journal|October 24, 2025
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Mathieu Wemeau, Laurène Fenwarth, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2024
Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosisGuillaume Lefèvre, Jean-Baptiste Gibier, Antonino Bongiovanni, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid DisordersDavid Fandrei, Jean Pegliasco, Florence Pasquier, et al.
Blood Advances|March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progressionLéa Fléchon, Inès Arib, Ankit K Dutta, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Pageof 15

Showing results (121-130 of 142) with videos related to

Sort By:
Pageof 15
Leukemia|March 27, 2026
Genetic alterations and measurable residual disease in core binding factor acute myeloid leukemiaLoïc Vasseur, Matthieu Duchmann, Nicolas Duployez, et al.
British Journal of Haematology|April 19, 2022
A randomised phase II study of azacitidine (AZA) alone or with Lenalidomide (LEN), Valproic acid (VPA) or Idarubicin (IDA) in higher-Risk MDS or low blast AML: GFM's "pick a winner" trial, with the impact of somatic mutationsLionel Adès, Nicolas Duployez, Agnes Guerci-Bresler, et al.
Blood|April 20, 2022
Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO studyNicolas Duployez, Laëtitia Largeaud, Matthieu Duchmann, et al.
Blood Cancer Journal|October 24, 2025
Diagnostic relevance of SH2B3 mutations in suspected myeloid malignancies and acute leukemia: insights from a large-scale NGS-based screening studyLeïla Ben Dhia, Mathieu Wemeau, Laurène Fenwarth, et al.
Rheumatology (Oxford, England)|February 17, 2022
Clonal haematopoiesis of indeterminate potential and cardiovascular events in systemic lupus erythematosus (HEMATOPLUS study)Clémence David, Nicolas Duployez, Philippine Eloy, et al.
The Journal of Allergy and Clinical Immunology|August 16, 2024
Interactions between eosinophils and IL-5Rα-positive mast cells in nonadvanced systemic mastocytosisGuillaume Lefèvre, Jean-Baptiste Gibier, Antonino Bongiovanni, et al.
Orphanet Journal of Rare Diseases|April 30, 2023
French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromesMatthieu Groh, Julien Rohmer, Nicolas Etienne, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 31, 2025
Clonal Evolution of PPM1D Mutations in the Spectrum of Myeloid DisordersDavid Fandrei, Jean Pegliasco, Florence Pasquier, et al.
Blood Advances|March 21, 2024
Genomic profiling of mycosis fungoides identifies patients at high risk of disease progressionLéa Fléchon, Inès Arib, Ankit K Dutta, et al.
Blood Advances|September 9, 2025
Allogeneic hematopoietic stem cell transplantation in patients with germ line DDX41 mutated myeloid malignanciesMichael Loschi, Marie-Charlotte Villy, Jacques-Emmanuel Galimard, et al.
Pageof 15